New thiazole carboxamides as potent inhibitors of Akt kinases
Authors:
- Zhang ZhangZZZhang Zhang
- Xiaoxi ZhuangXZXiaoxi Zhuang
- Jinfeng LuoJLJinfeng Luo
- Xianwen CaoXCXianwen Cao
- Honglin LiHLHonglin Li
- Zhengchao TuZTZhengchao Tu
- Xiaoyun LuXLXiaoyun Lu
- Xiaomei RenXRXiaomei Ren
- Ke DingKDKe Ding
- 1 January 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (2) , 1208-1212
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (21072192)
- National Nature Science Foundation of China (81001446)
This publication has 27 references indexed in Scilit:
- The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase InhibitorsCurrent Cancer Drug Targets, 2008
- Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studiesBioorganic & Medicinal Chemistry Letters, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- The Akt/PKB pathway: molecular target for cancer drug discoveryOncogene, 2005
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting2005
- Design and Crystal Structures of Protein Kinase B-Selective Inhibitors in Complex with Protein Kinase A and MutantsJournal of Medicinal Chemistry, 2004
- The protein kinase B/Akt signalling pathway in human malignancyCellular Signalling, 2002
- Molecular cloning, expression and characterization of the human serine/threonine kinase Akt‐3European Journal of Biochemistry, 1999